In a landmark development underscoring the global race for obesity treatments, US pharmaceutical giant Pfizer has secured a ten billion dollar takeover of Metsera. The deal follows an intense bidding
In a landmark development underscoring the global race for obesity treatments, US pharmaceutical giant Pfizer has secured a ten billion dollar takeover of Metsera. The deal follows an intense bidding
Two of the world’s largest pharmaceutical conglomerates have become embroiled in an escalating takeover battle for Metsera, an emerging biotech on the verge of breakthroughs in weight-loss drug innovation. Novo
Billions of pounds were added to the market value of British and global pharmaceutical companies on Wednesday following a major relief rally prompted by the Trump administration’s latest stance on
Pharmaceutical giant Pfizer is now embroiled in a major class action lawsuit in the United States, as more than 1,300 women allege they developed brain tumours following use of its
The American pharmaceutical giant Pfizer has discontinued the development of its experimental weight-loss pill following safety concerns, marking a significant setback in its pursuit of the lucrative anti-obesity market, estimated
Pfizer has completed the sale of its remaining 7% stake in Haleon, the FTSE 100 consumer healthcare company, raising £2.4 billion. This transaction, involving the placement of 618 million shares






